共查询到20条相似文献，搜索用时 703 毫秒
1.
试验应用鸡球虫弱毒苗的3种剂型,微囊型一丸口服（灌服）疫苗、微囊型拌料疫苗和液状滴服疫苗,按照各自的免疫方法进行鸡球虫免疫,以增重量、饲料转化率和每克粪便卵囊数等为指标,综合判定微囊型疫苗的免疫效果,同时比较这3种免疫方法在免疫效果上存在的差异。试验结果表明,微囊型球虫疫苗无论是直接灌服免疫还是拌料免疫都能够产生与液态滴服疫苗相似的免疫效果,组间差异不显著,但与感染对照组间的差异显著。试验证明,微囊型一丸口服（灌服）疫苗和微囊型拌料疫苗应用于鸡球虫病的免疫预防是可行的。可通过的临床免疫效果试验获取更多实验数据,为球虫疫苗的研制和应用奠定理论基础。 相似文献
2.
《中国兽医杂志》2017,(7)
为检验本课题研制的球虫疫苗免疫增效助悬剂对疫苗免疫效果的功效。通过测定免疫攻毒鸡的相对增重率、死亡率、病变记分、卵囊减少率等来观察和分析鸡球虫病疫苗免疫增效助悬剂对疫苗免疫产生期的影响。结果显示,与饮水对照组相比,增效助悬剂组的相对饮水率为105.89%;一次免疫,增效剂免疫组和免疫对照组鸡群已能对大剂量强毒株攻击产生保护力,但病变记分均≥1,相对增重未达到80%,未达到良好免疫效果;二次免疫,增效剂免疫攻毒组于二免后第6天产生良好免疫保护,免疫对照组于二免后第7天达到良好免疫效果。表明球虫疫苗免疫增效助悬剂不影响雏鸡饮水,且使用该助悬剂可缩短免疫产生期。 相似文献
3.
鸡球虫微囊型口服疫苗免疫效果的初步研究 总被引：5，自引：0，他引：5
应用本研究室研制的微囊型口服鸡球虫疫苗,通过拌料口服免疫法,测定了微囊型口服鸡球虫疫苗不同免疫次数的免疫效果.实验结果表明：经两次拌料口服免疫的鸡只在实验性攻虫后,其发病率、死亡率、病变记分、血便记分、料肉比等各项指标均低于一次免疫组和感染对照组,说明在免疫两次后鸡机体对鸡球虫产生了较好的免疫力,有了明显的抵抗鸡球虫的能力,而只免疫一次的鸡只较免疫两次的鸡只抗鸡球虫的能力弱.微囊型口服鸡球虫疫苗使用方便,易于在生产中推广使用. 相似文献
4.
L-NMMA对鸡球虫早熟弱毒疫苗免疫鸡增重的影响 总被引：1，自引：1，他引：0
为了研究鸡球虫早熟弱毒疫苗对免疫鸡增重的影响及一氧化氮合成酶抑制剂(L-NMMA)对免疫鸡增重和免疫效果的影响。取40只SPF雏鸡,分为空白对照组(C1、C2)和单剂量重复接种组(T1、T2),T1、T2组按推荐免疫剂量单剂量重复接种鸡球虫早熟弱毒疫苗,C1和T1、C2和T2分别于二次接种后第7、14天逐只空腹称重,剖检记录十二指肠、空肠和盲肠病变记分,取心脏、肝脏、脾脏、肺脏、肾脏、腺胃、肌胃、十二指肠、空肠和盲肠进行病理组织学检查。另选取40只SPF雏鸡,分为空白对照组C20、攻毒对照组T21、免疫对照组T22和免疫加药组T23,T22和T23按推荐免疫剂量两次免疫鸡球虫早熟弱毒疫苗,T23在免疫的同时腹腔注射L-NMMA,二免后第14天T21、T22和T23均接种鸡球虫混合强毒,测定SPF雏鸡平均增重、相对增重、肠道(十二指肠、空肠和盲肠)病变记分、病变记分减少率(RLS)、血便记分、死亡率及卵囊产量等指标。结果显示,接种组的平均增重显著低于未接种组(P<0.05),接种组的十二指肠、空肠和盲肠有轻微病变且黏膜上皮细胞均有不同程度损伤和脱落;免疫加L-NMMA组一免、二免后及攻毒后试验鸡的平均增重均极显著高于免疫攻毒对照组(P<0.01),且与空白对照组鸡的平均增重无显著差异(P>0.05),且免疫对照组和免疫加药组肠道病变记分和卵囊产量无显著差异(P>0.05)。说明鸡球虫早熟弱毒疫苗对雏鸡肠道有轻微损伤,且对鸡增重有一定影响;L-NMMA可降低鸡球虫早熟弱毒疫苗对试验鸡增重的影响,且不影响疫苗的免疫效果。 相似文献
5.
为了研究鸡球虫早熟弱毒疫苗对免疫鸡增重的影响及一氧化氮合成酶抑制剂(L-NMMA)对免疫鸡增重和免疫效果的影响。取40只SPF雏鸡,分为空白对照组(C1、C2)和单剂量重复接种组(T1、T2),T1、T2组按推荐免疫剂量单剂量重复接种鸡球虫早熟弱毒疫苗,C1和T1、C2和T2分别于二次接种后第7、14天逐只空腹称重,剖检记录十二指肠、空肠和盲肠病变记分,取心脏、肝脏、脾脏、肺脏、肾脏、腺胃、肌胃、十二指肠、空肠和盲肠进行病理组织学检查。另选取40只SPF雏鸡,分为空白对照组C20、攻毒对照组T21、免疫对照组T22和免疫加药组T23,T22和T23按推荐免疫剂量两次免疫鸡球虫早熟弱毒疫苗,T23在免疫的同时腹腔注射L-NMMA,二免后第14天T21、T22和T23均接种鸡球虫混合强毒,测定SPF雏鸡平均增重、相对增重、肠道(十二指肠、空肠和盲肠)病变记分、病变记分减少率(RLS)、血便记分、死亡率及卵囊产量等指标。结果显示,接种组的平均增重显著低于未接种组(P0.05),接种组的十二指肠、空肠和盲肠有轻微病变且黏膜上皮细胞均有不同程度损伤和脱落;免疫加L-NMMA组一免、二免后及攻毒后试验鸡的平均增重均极显著高于免疫攻毒对照组(P0.01),且与空白对照组鸡的平均增重无显著差异(P0.05),且免疫对照组和免疫加药组肠道病变记分和卵囊产量无显著差异(P0.05)。说明鸡球虫早熟弱毒疫苗对雏鸡肠道有轻微损伤,且对鸡增重有一定影响;L-NMMA可降低鸡球虫早熟弱毒疫苗对试验鸡增重的影响,且不影响疫苗的免疫效果。 相似文献
6.
7.
8.
鸡球虫病是一种呈全球性分布、侵害鸡体肠道继而出现以肿胀和出血等临床症状的原虫病,长期利用化学药物防治球虫病,造成了耐药和药物残留两大问题。由此,人们利用球虫疫苗预防球虫病愈加普遍,国内外相继问世一系列球虫病疫苗,主要以弱毒和强毒活疫苗为主。球虫疫苗免疫成功与否不仅仅与疫苗本身的质量有关,还和使用球虫疫苗的过程有关。本文结合临床经验主要作以下几个方面介绍。 相似文献
9.
姜黄素肠道修复剂对鸡球虫病疫苗免疫效果的影响 总被引：1，自引：0，他引：1
为研究姜黄素肠道修复剂对鸡球虫病疫苗免疫效果的影响,在球虫疫苗免疫时加入姜黄素肠道修复剂,通过观察测定免疫组鸡群的精神状况、首免卵囊排泄量、疫苗反应期的肠道病变记分和增重以及免疫后21 d攻虫的保护效果进行综合评价。结果显示:在免疫期,姜黄素实验组鸡只的精神状况良好,首免卵囊量排泄正常,疫苗反应期的肠道病变记分和增重比未加姜黄素实验组的要好些;21 d攻虫后,姜黄素实验组的相对增重高于未加姜黄素实验组,但差异性不显著(P0.05),而且姜黄素实验组的肠道病变记分和粪便记分均低于未加姜黄素实验组。试验表明,姜黄素在球虫疫苗免疫过程中能够修复肠道损伤、提升肠道健康,对球虫疫苗免疫具有较好的辅助性作用。 相似文献
10.
鸡球虫病四价活疫苗对毒害艾美耳球虫和柔嫩艾美耳球虫的免疫效果观察 总被引：2，自引：0，他引：2
为评价一种商品化鸡球虫病四价活疫苗[柔嫩艾美耳球虫(E.tenella)、毒害艾美耳球虫(E.necatrix)、巨型艾美耳球虫和堆型艾美耳球虫]对E.necatrix和E.tenella的免疫保护效果,本研究基于试验鸡血便记分、存活率、相对增重率、病变值、卵囊值及抗球虫指数(ACI)等指标对其免疫效果进行检测.结果表明,免疫攻虫组抗E.necatrix和E.tenella的ACI分别为157.3和135.6,均低于160,表明该球虫疫苗抗两种球虫的效果均为低效.然而,免疫攻虫组鸡血便数量、血便记分、增重、卵囊产量和病变记分等指标均优于阳性对照组.综合指标显示,该疫苗对E.necatrix和E.tenella具有一定的免疫保护力,但单纯采用疫苗并不能够达到防控鸡球虫病的目的. 相似文献
11.
选用两种在山东省普遍使用的中等毒力IBD疫苗,将试验分成12组,分别在12日龄和19日龄两次免疫商品鸡,同时在11日龄时用低聚异麦芽糖饮水,连用7天,二免后13天人工接种vvIBDV,连续观察14天。根据血清学检测指标,囊指数,BBIX值,病理组织学检查,临床保护率和病理保护率结果,都充分表明低聚异麦芽糖对传染性法氏囊病中等毒力疫苗具有显著的免疫增强作用,而且对提高法氏囊等免疫器官的保护作用及疫苗对其损伤后的修复作用也有显著效果。 相似文献
12.
低聚异麦芽糖对IBD中等毒力疫苗免疫增强作用的研究 总被引：2，自引：0，他引：2
选用两种在山东省普遍使用的中等毒力IBD疫苗,将试验分成12组,分别在12日龄和19日龄两次免疫商品鸡,同时在10日龄时用低聚异麦芽糖饮水,连用7d,二免后13d人工接种vvIBDV,连续观察14d。根据血清学检测指标、囊指数、BBIX值、病理组织学检查、临床保护率和病理保护率结果,都充分表明低聚异麦芽糖对传染性法氏囊病中等毒力疫苗具有显著的免疫增强作用,而且对提高法氏囊等免疫器官的保护作用及疫苗对其损伤后的修复作用也有显著效果。 相似文献
13.
选用两种在山东省普遍使用的中等毒力IBD活疫苗,将240只试验用商品鸡分成12组,分别在12日龄和19日龄两次免疫,同时在11日龄时用复合中草药提取物饮水,连用7 d,二免后13 d人工接种vvIBDV,连续观察14 d。结果表明,无论从抗体水平、囊指数、BBIX值、B淋巴细胞EAC花环形成率、T淋巴细胞ANAE阳性率、红细胞(RBC)免疫黏附功能,还是从病理组织学检查、临床保护率、病理保护率等指标来看,都充分表明该复合中草药提取物对中等毒力IBD活疫苗具有显著的免疫增强作用,而且对提高法氏囊等免疫器官的保护作用及疫苗对其损伤后的修复作用也有显著效果。 相似文献
14.
Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses 总被引：3，自引：0，他引：3
Witter RL 《Avian diseases》2002,46(4):925-937
Studies were conducted to better understand the relationship among Marcek's disease (MD) vaccine strains between induction of protective immunity and the degree of attenuation (or virulence). To obtain viruses at different stages of attenuation, very virulent plus MD strains 584A and 648A and selected clones of these strains were serially passaged in chicken and duck cells. These viruses were considered fully attenuated after passage for 70-100 times in chicken embryo cell cultures until they no longer induced gross lesions in susceptible, maternal antibody-negative (ab-) chickens. Lower passages of the same strains were considered partially attenuated, provided their virulence was less than that of the parent strain. Four of five partially attenuated preparations derived from MD virus strains 584A and 648A or the previously attenuated Md11 strain induced 28%-62% higher levels of protection in maternal antibody-positive (ab+) chickens against virulent MD challenge than the fully attenuated counterpart viruses. The partially attenuated 584A/d2/3 strain replicated in chickens but was totally nonprotective. Data from two subsequent trials in ab+ chickens confirmed that protection induced by the partly attenuated (passage 80) preparations was 79% and 118% higher, respectively, than that induced by the fully attenuated (passage 100) preparations of strain 648A. However, in one trial with ab- chickens, no difference in protection between partially and fully attenuated virus was observed. Strong protection (up to 85%) against highly virulent challenge also was provided by preparations of 648A at passages 40-60, which were moderately oncogenic when used alone. Partially attenuated strains tended to replicate to higher titers in both ab+ and ab- chickens compared with fully attenuated vaccines. Also, ab+ and ab- chickens vaccinated with partially attenuated strains developed three- to nine fold more extensive microscopic lesions in peripheral nerves at 14 and 22 days after virulent challenge than chickens vaccinated with fully attenuated strains. When measured in ab+ chickens, loss of lesion induction by 648A was achieved 30 passages earlier (at passage 70) than when measured in ab- chickens. Thus, maternal antibodies appeared to abrogate the pathogenicity of some partially attenuated strains. These studies establish for MD the principle that at least some partially attenuated MD viruses may replicate better and induce stronger immunity against virulent challenge than fully attenuated preparations of the same strain, at least when tested in ab+ chickens. Moreover, depending on passage level, partially attenuated vaccine strains may be relatively innocuous for ab+ chickens, causing few or no lesions. 相似文献
15.
本文报告不同剂量禽霍乱蜂胶灭活疫苗对雏鸡免疫的安全性和效果，按雏难的日龄分成Ⅰ组，Ⅱ组，Ⅲ组，Ⅳ组共４组。结果，Ⅰ组接种０．３ｍｌ，０．４ｍｌ，０．５ｍｌ苗的鸡反应率分别为１６．７４％，１６．７６，１７．７９％，免疫后３个月统计，死亡率分别为３．０９％，２．８５％，２．８９％。Ⅱ组接种０．３ｍｌ，０．５ｍｌ，０．７ｍｌ苗的反应率分别为１２．８２％，１３．８３％，１６．２６％，死亡率分别为４．２９％ 相似文献
16.
Experiments were carried out to establish an infection and disease model for Clostridium perfringens in broiler chickens. Previous experiments had failed to induce disease and only a transient colonization with challenge strains had been obtained. In the present study, two series of experiments were conducted, each involving four groups of chickens with each group kept in separate isolators. A coccidial vaccine given at 10 times the prescribed dosage was used to promote the development of necrotic enteritis. In the first experiment, cultures of C. perfringens were mixed with the feed at day 9, 10, 11, and 12, and the coccidial vaccine was given at day 10, whereas in the second experiment, C. perfringens cultures were mixed with the feed at day 17, 18, 19, and 20, and the coccidial vaccine was given at day 18. Chickens were examined at day 9, 11, 12, and 15 (Experiment 1), and at day 17, 18, 20, and 24 (Experiment 2). There was no mortality in any of the groups; however, chickens in the groups receiving both coccidial vaccine and C. peifringens developed the subclinical form of necrotic enteritis, demonstrated by focal necroses in the small intestine, whereas chickens in control groups or groups receiving only coccidial vaccine or only C. perfringens cultures developed no necroses. The results underline the importance of predisposing factors in the development of necrotic enteritis. 相似文献
17.
18.
ZHANG Zhen-hua LI Lin JING Xiao-dong ZHANG Jian-wei SHEN Jia SHI Ai-hua ZHENG Xiao-lan HUANG Feng-jun JIANG Bei-yu 《中国畜牧兽医》2015,42(12):3338-3343
One-day-old moderate maternal antibody Jinghong chickens and SPF chickens were vaccinated with infectious bursal disease (IBD) immune complex (IC) vaccine and BX strain live vaccine,respectively,pathological changes of bursa of fabricius in chickens were observed at the 9th day after immunization.On the 28th day after immunization,blood samples were taken and the IBDV neutralizing antibody were tested,meanwhile experimental chickens were challenged with high virulent IBDV,the protective rates of experimental groups were calculated.The results showed that at the 9th day after immunization,the bursa of fabricius in SPF and Jinghong chickens were normal in IC vaccine group,however atrophic changes of bursa of fabricius in BX strain live vaccine group were shown.At the 28th day after immunization,the IBDV neutralizing antibody of IC vaccine group and BX strain live vaccine group in SPF and Jinghong chickens were 9.2log2,8.5log2,7.2log2 and 4.4log2,respectively,while 100% protection rates were provided.The results provided that IC vaccine had better immunity effect on one-day-old moderate maternal antibody chicken,high levels of neutralizing antibodies against IBDV were produced and protection rates were 100%. 相似文献
19.
将鸡传染性法氏囊病免疫复合物疫苗和BX株活疫苗分别免疫1日龄中等母源抗体水平京红雏鸡,同时免疫1日龄SPF雏鸡作对照,免疫后第9天观察法氏囊病变,免疫后第28天采血测定IBDV中和抗体,并用强毒攻击,计算各组疫苗保护率。结果显示,免疫后第9天,免疫复合物疫苗组SPF雏鸡和京红雏鸡法氏囊均正常,BX株活疫苗组SPF雏鸡法氏囊出现了萎缩病变;免疫后第28天,对照SPF雏鸡和京红雏鸡的免疫复合物疫苗组、BX活疫苗组IBDV中和抗体效价分别为9.2log2、8.5log2和 7.2log2、4.4log2,攻毒保护率均为100%。试验结果表明免疫复合物疫苗免疫1日龄中等水平母源抗体雏鸡效果很好,能产生较高的中和抗体,攻毒保护率能达到100%。 相似文献
20.
鸡沙门氏菌弱毒苗与微生态制剂联合应用的效果 总被引：4，自引：0，他引：4
将鸡沙门氏菌弱毒苗分别与2种不同的微生态制剂配合对AA肉鸡实施免疫。结果表明，弱毒苗单独应用组、联合应用1组和2组的免疫保护效率分别为75％、90％和90％，均与攻毒对照组（40％）存在显著差异（P＜0．05）；攻毒20d后所有存活鸡细菌分离结果显示，上述3个试验组细菌分离率分别为53．5％、55％和5．5％，也均与攻毒对照组（75％）存在显著性差异（P＜0．05）。由此认为，该弱毒苗与上述微生态制剂联合应用的效果明显，具有较好的应用前景。 相似文献